CHRNB2 and gastric cancer: Our group previously conducted a comprehensive gene expression analysis of biological samples from patients with metastatic gastric cancer and identified aberrantly high expression of the cholinergic receptor nicotinic beta 2 subunit (CHRNB2) in cases with distant metastases [15].